Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients

Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients

<b>Background</b>: Studies investigating the long-term cellular immune response to SARS-CoV-2 mRNA vaccines in patients with inflammatory bowel disease (IBD) remain limited, particularly among those receiving immunosuppressive therapy. <b>Methods</b>: We prospectively evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Mayorga Ayala, Claudia Herrera-deGuise, Juliana Esperalba, Xavier Martinez-Gomez, Elena Céspedes Martinez, Xavier Serra Ruiz, Virginia Robles, Ernesto Lastiri, Zahira Perez, Elena Oller, Candela Fernandez-Naval, Mónica Martinez-Gallo, Francesc Casellas, Natalia Borruel
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Cells
Subjects:
SARS-CoV2 vaccine
inflammatory bowel disease
cellular response
thiopurines
Online Access:https://www.mdpi.com/2073-4409/14/15/1156
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/14/15/1156

Similar Items